In our latest healthcare sector report we look at the interesting developments that have taken place over the summer in RNA-based medicine, pharma companies to use genetic data from consumer tests and changing regulations on the Hong Kong Stock Exchange allowing prerevenue biotech companies to be listed.

Click here to download the report >>